Filing Details
- Accession Number:
- 0000899243-21-036768
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-21 16:05:17
- Reporting Period:
- 2021-09-20
- Accepted Time:
- 2021-09-21 16:05:17
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1736359 | M James Mock | 940 Winter Street Waltham MA 02451 | Please See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-09-20 | 1,300 | $183.18 | 28,024 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-20 | 1,803 | $183.93 | 26,221 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-20 | 1,377 | $185.30 | 24,844 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-20 | 400 | $186.09 | 24,444 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-20 | 1,100 | $187.17 | 23,344 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-09-20 | 100 | $187.99 | 23,244 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by Mr. Mock on August 20, 2021.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $182.58 to $183.52. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $183.60 to $184.16. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $184.75 to $185.70. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $185.75 to $186.62. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $186.83 to $187.78. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.